Results 341 to 350 of about 324,464 (367)
Some of the next articles are maybe not open access.

Anticoagulants

2006
Because of the narrow therapeutic index of warfarin and unfractionated heparin (UFH), monitoring their anticoagulant effects is required. On the other hand, lowmolecular- weight heparin (LMWH) and fibrinolytic agents need to be monitored only under certain circumstances.
Richard C. Becker, Frederick A. Spencer
openaire   +1 more source

Anticoagulation in Pregnancy

Cardiology Clinics, 2012
Pregnancy-associated thrombosis is an important cause of morbidity and mortality during pregnancy. Anticoagulation therapy is an important component of the management of thrombotic complications in pregnancy but may result in fetal and maternal complications.
Sorel Goland, Uri Elkayam
openaire   +3 more sources

Anticoagulation in the elderly

Current Opinion in Pulmonary Medicine, 2001
Oral anticoagulation therapy has demonstrated benefit in the treatment and prevention of a variety of thromboembolic disorders. Most individuals who receive oral anticoagulant therapy are elderly patients with nonvalvular atrial fibrillation and acute or recurrent venous thromboembolism.
Richard H. White, Mark C Henderson
openaire   +2 more sources

The lupus anticoagulant

Arthritis & Rheumatism, 1976
AbstractThe clinical and laboratory experience with the lupus anticoagulant was reviewed in 37 patients. The anticoagulant is thought to act by blocking the activation of prothrombin by the prothrombin activator complex of factors Xa, V, and phospholipid.
Michael Boxer   +2 more
openaire   +3 more sources

Anticoagulants and Anticoagulation

Medical Clinics of North America, 1976
Christos B. Moschos, Murray Nussbaum
openaire   +3 more sources

Therapeutic anticoagulation

2010
Low molecular weight heparins (LMWH) have largely replaced unfractionated heparin. Their much more predictable anticoagulant response combined with high bioavailability after subcutaneous injection means that the dose can be calculated by body weight and given subcutaneously without any monitoring or dose adjustment.
openaire   +1 more source

Anticoagulants in Pregnancy

Journal of Thrombosis and Thrombolysis, 2006
Venous thromboembolic (VTE) complications are a leading cause of maternal mortality in the developed world. To reduce the incidence of VTE in pregnancy, and improve outcomes, a wider understanding of the risk factors involved and a better identification of women at risk of thrombosis coupled with effective thromboprophylaxis and treatment of VTE are ...
openaire   +3 more sources

Anticoagulant Therapy

AJN, American Journal of Nursing, 1964
J H, OLWIN, J L, KOPPEL
openaire   +2 more sources

ANTICOAGULANTS

Medical Journal of Australia, 1956
openaire   +2 more sources

Home - About - Disclaimer - Privacy